Literature DB >> 16485110

[Anesthesia in patients with glucose-6-phosphate dehydrogenase deficiency: case report and perioperative anesthesiologic management].

A L Depta1, G Erdös, C Werner.   

Abstract

Glucose-6-phosphate dehydrogenase (G6PD) deficiency, a frequent congenital human enzyme defect, is the most frequent cause of hemolytic anemia triggered by drugs or infectious diseases. Drugs which induce acute hemolysis in patients with G6PD deficiency are often used in anesthesia and perioperative pain therapy. Considering the fact that patients from geographic regions with a high prevalence of the disease are often treated in European hospitals, special attention should be paid to this problem. We report a case of a 30-year-old female patient with favism and review the disease and anesthesia-related implications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16485110     DOI: 10.1007/s00101-005-0971-6

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  16 in total

1.  Clinical problem-solving. Why "why" matters.

Authors:  William J Janssen; Gurpreet Dhaliwal; Harold R Collard; Sanjay Saint
Journal:  N Engl J Med       Date:  2004-12-02       Impact factor: 91.245

Review 2.  Pathophysiology of hemolysis in glucose-6-phosphate dehydrogenase deficiency.

Authors:  P Arese; A De Flora
Journal:  Semin Hematol       Date:  1990-01       Impact factor: 3.851

3.  Hemolytic anemia after methylene blue therapy for aniline-induced methemoglobinemia.

Authors:  Yao-Pan Liao; Dong-Zong Hung; Dar-Yu Yang
Journal:  Vet Hum Toxicol       Date:  2002-02

4.  Distribution of red cell G6PD and 6PGD phenotypes in Saudi Arabia.

Authors:  A P Samuel; N Saha
Journal:  Trop Geogr Med       Date:  1986-09

5.  Failure of methylene blue treatment in toxic methemoglobinemia. Association with glucose-6-phosphate dehydrogenase deficiency.

Authors:  P J Rosen; C Johnson; W G McGehee; E Beutler
Journal:  Ann Intern Med       Date:  1971-07       Impact factor: 25.391

6.  N-acetylcysteine reduces methemoglobin in an in-vitro model of glucose-6-phosphate dehydrogenase deficiency.

Authors:  R O Wright; A D Woolf; M W Shannon; B Magnani
Journal:  Acad Emerg Med       Date:  1998-03       Impact factor: 3.451

7.  Glucose-6-phosphate dehydrogenase and glutathione reductase activity in methemoglobin reduction by methylene blue and cystamine. Study on glucose-6-phosphate dehydrogenase-deficient individuals, on normal subjects and on riboflavin-treated subjects.

Authors:  B Barraviera; P E Machado; D A Meira; P R Curi; J N Martins; M J de Souza
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1988 Sep-Oct       Impact factor: 1.846

Review 8.  Variants of glucose-6-phosphate dehydrogenase are due to missense mutations spread throughout the coding region of the gene.

Authors:  T Vulliamy; E Beutler; L Luzzatto
Journal:  Hum Mutat       Date:  1993       Impact factor: 4.878

9.  Severe hemolysis and renal failure in glucose-6-phosphate dehydrogenase deficient patients with hepatitis E.

Authors:  Shahab Abid; A Haleem Khan
Journal:  Am J Gastroenterol       Date:  2002-06       Impact factor: 10.864

Review 10.  Glucose-6-phosphate dehydrogenase deficiency and malaria.

Authors:  C Ruwende; A Hill
Journal:  J Mol Med (Berl)       Date:  1998-07       Impact factor: 4.599

View more
  1 in total

1.  Ultrasound-Guided Regional Anesthesia in a Glucose-6-Phosphate Dehydrogenase (G6PD)-Deficient Geriatric Trauma Patient.

Authors:  Agnes M Födinger; Christian Kammerlander; Thomas J Luger
Journal:  Geriatr Orthop Surg Rehabil       Date:  2012-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.